These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 17188750)
1. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. Poutsiaka DD; Skiffington S; Miller KB; Hadley S; Snydman DR J Infect; 2007 Jun; 54(6):567-71. PubMed ID: 17188750 [TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L. Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176 [TBL] [Abstract][Full Text] [Related]
3. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia. Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222 [TBL] [Abstract][Full Text] [Related]
4. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients. Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253 [TBL] [Abstract][Full Text] [Related]
5. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary? King EA; McCoy D; Desai S; Nyirenda T; Bicking K J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178 [TBL] [Abstract][Full Text] [Related]
6. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections. Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Britt NS; Potter EM; Patel N; Steed ME Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715 [TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia. Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331 [TBL] [Abstract][Full Text] [Related]
9. Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin. Bethea JA; Walko CM; Targos PA Ann Pharmacother; 2004 Jun; 38(6):989-91. PubMed ID: 15100393 [TBL] [Abstract][Full Text] [Related]
11. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan. Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639 [TBL] [Abstract][Full Text] [Related]
12. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia. Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529 [TBL] [Abstract][Full Text] [Related]
13. Emergence of daptomycin-resistant VRE: experience of a single institution. Kamboj M; Cohen N; Gilhuley K; Babady NE; Seo SK; Sepkowitz KA Infect Control Hosp Epidemiol; 2011 Apr; 32(4):391-4. PubMed ID: 21460492 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting. Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401 [TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Britt NS; Potter EM; Patel N; Steed ME Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602 [TBL] [Abstract][Full Text] [Related]
16. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study. Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924 [TBL] [Abstract][Full Text] [Related]
17. Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus. Patel K; Kabir R; Ahmad S; Allen SL J Oncol Pharm Pract; 2016 Apr; 22(2):212-8. PubMed ID: 25326010 [TBL] [Abstract][Full Text] [Related]
18. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Bossaer JB; Hall PD; Garrett-Mayer E Support Care Cancer; 2010 Feb; 19(2):231-7. PubMed ID: 20069435 [TBL] [Abstract][Full Text] [Related]
19. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid? Mave V; Garcia-Diaz J; Islam T; Hasbun R J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543 [TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. Twilla JD; Finch CK; Usery JB; Gelfand MS; Hudson JQ; Broyles JE J Hosp Med; 2012 Mar; 7(3):243-8. PubMed ID: 22076962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]